Water Deprivation Protocol
NCT01224704 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75
Last updated 2026-05-22
Summary
Background:
\- One area in which obese and lean individuals may be different is how their bodies handle water balance and thirst. Studies done in animals suggest that individuals with greater body fat may tolerate periods without water better than lean animals. Other research has found a link between the ability to tolerate periods without water and increased body weight. Researchers are interested in studying whether the ability to tolerate periods without water and ability to feel thirst might differ in lean versus obese individuals.
Objectives:
\- To evaluate the effects of water deprivation and feelings of thirst in lean and obese individuals.
Eligibility:
\- Healthy individuals at least 18 years of age who are either lean (body mass index less than 26 kg/m(2)) or obese (body mass index at least 35 kg/m(2)).
Design:
* Participants will be screened with a medical history, physical examination, and blood and urine tests.
* Participants will spend the entire study (13 days) as inpatients at the National Institutes of Health Clinical Center.
* Participants will have the following tests and procedures:
* Body composition assessment (using low-level x-rays) to determine the percentage of fat tissue in the body.
* Oral glucose tolerance test (similar to that often used to diagnose diabetes). Individuals who are suspected to have diabetes will not be allowed to continue with the study.
* High salt infusion test, in which an infusion of saline (salt water) will be given for 2 hours and participants will respond to questions about how hungry and thirsty they feel during the procedure.
* Water deprivation test, in which participants will go for 24 hours without water or food and respond to questions about how hungry and thirsty they feel.
* 24-hour stay in a metabolic chamber to determine how many calories participants burn in a day.
* A series of questionnaires about participants' eating habits, feelings about food, and personal feelings, as well as computer-based tests involving the performance of various tasks.
* Measurement of free-living energy using doubly-labeled water, in which participants will drink a sample of water with extra-heavy atoms of hydrogen and oxygen to evaluate the amount of water in the body.
* 24-hour urine collection.
* Frequent blood samples, urine collection, and fat tissue biopsies during the various study procedures.
* After the end of the 13-day study, participants will return after 1 week for a final urine collection.
Conditions
Interventions
- OTHER
-
Hypertonic saline infusion
Three percent saline (0.1ml/kg of the lean mass/min) will be infused for 120 minutes.
- OTHER
-
Water deprivation
24 hour water deprivation
Sponsors & Collaborators
-
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
lead NIH
Principal Investigators
-
Marci E Gluck, Ph.D. · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-10-19
- Primary Completion
- 2018-09-09
- Completion
- 2019-03-28
Countries
- United States
Study Locations
More Related Trials
-
Rehydration Efficiency During Ad-libitum Fluid Intake
NCT06414291 ·Status: COMPLETED ·Phase: NA
-
Parenteral Hydration in Advanced Cancer Patients
NCT00423722 ·Status: COMPLETED ·Phase: NA
-
Evaluating Ileostomy Hydration Protocol
NCT04669964 ·Status: WITHDRAWN
-
Clinical Trial to Evaluate the Effects of Two Novel Hydration Beverage Formulas on Rehydration in Healthy Adults
NCT05428761 ·Status: COMPLETED ·Phase: NA
-
Fluid Balance During Exercise in the Heat With Water, Flavored Placebo, or a Carbohydrate-electrolyte Beverage Intake (The APEX Study)
NCT01893853 ·Status: COMPLETED ·Phase: NA
-
Effect of Sodium Concentration of Priming and Rinsing Fluids on Weight Gain
NCT01168947 ·Status: COMPLETED ·Phase: NA
-
Rehydration Following Exercise-Induced Dehydration
NCT01974986 ·Status: COMPLETED ·Phase: NA
-
Patient Controlled Fluid Administration
NCT03176043 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Non-invasive Fluid Management
NCT02892799 ·Status: UNKNOWN ·Phase: NA
-
Physiological Effects of 38°C vs. 22°C Fluid Therapy in Critically Ill Patients
NCT04576806 ·Status: WITHDRAWN ·Phase: NA
-
Using Hydration Monitor to Detect Changes in the Hydration Status Athletes
NCT02206581 ·Status: COMPLETED
-
Tolvaptan to Reduce Length of Stay in Hospitalized Patients With Cirrhosis and Hyponatremia
NCT01890694 ·Status: TERMINATED ·Phase: PHASE4
-
Goal Directed Fluid Therapy
NCT00860704 ·Status: COMPLETED ·Phase: PHASE4
-
Use of a Mini-fluid Bolus to Identify Fluid Responsiveness
NCT03058653 ·Status: WITHDRAWN ·Phase: NA
-
The Efficacy of Oral Versus Intravenous Hypertonic Saline Administration in Runners With Exercise-Associated Hyponatremia
NCT01110655 ·Status: UNKNOWN ·Phase: NA
-
Oral Rehydration Therapy in Burn Patients
NCT02124265 ·Status: TERMINATED ·Phase: PHASE1
-
Use of Isotonic Solutions Versus Hypotonic Solutions for Preventing Hospital Acquired Hyponatremia
NCT01909336 ·Status: COMPLETED ·Phase: PHASE3
-
Midodrine for the Treatment of Refractory Hypotension
NCT01531959 ·Status: COMPLETED ·Phase: PHASE3
-
Exploring Water-free Sodium Storage
NCT06872645 ·Status: RECRUITING ·Phase: NA
-
Fluid and Salt Restriction in Decompensated Heart Failure Patients
NCT01133236 ·Status: COMPLETED ·Phase: NA
-
The Effect of Oral Hypotonic Hydration in Isolated Oligohydramnios
NCT05332015 ·Status: COMPLETED ·Phase: NA
-
Neuromuscular Blockade for Post-Cardiac Arrest Care
NCT02260258 ·Status: COMPLETED ·Phase: PHASE2
-
Kinetic Method to Detect Dehydration
NCT01062776 ·Status: COMPLETED ·Phase: PHASE1
-
Crystalloids Versus Colloids Versus Hypertonic Saline as a Co-load During Spinal Anesthesia.
NCT03681847 ·Status: COMPLETED ·Phase: NA
-
High Sodium Diet and External Abdominal Compression in POTS
NCT01771484 ·Status: TERMINATED ·Phase: PHASE1